Literature DB >> 426501

Susceptibility of gram-negative aerobic bacilli resistant to carbenicillin in a general hospital to piperacillin and ticarcillin.

J E McGowan, P M Terry.   

Abstract

During an 8-month period, 858 gram-negative aerobic rods resistant to carbenicillin (minimum inhibitory concentration, >/=128 mug/ml) were isolated. Susceptibility testing of 233 of these suggested that piperacillin might be active against more of these organisms than would carbenicillin or ticarcillin.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 426501      PMCID： PMC352614          DOI： 10.1128/AAC.15.1.137

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  8 in total

1.  The usefulness of in vitro sensitivity tests in antibiotic therapy.

Authors:  R G PETERSDORF; J J PLORDE
Journal:  Annu Rev Med       Date:  1963       Impact factor: 13.739

2.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

3.  Evaluation of the micro-media system for quantitative antimicrobial drug susceptibility testing: a collaborative study.

Authors:  A L Barry; R N Jones; T L Gavan
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

4.  In vitro and in vivo antibacterial activity of T-1220, a new semisynthetic penicillin.

Authors:  K Ueo; Y Fukuoka; T Hayashi; T Yasuda; H Taki; M Tai; Y Watanabe; I Saikawa; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

5.  Piperacillin, a new penicillin active against many bacteria resistant to other penicillins.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

6.  In vitro activity of piperacillin, a new semisynthetic penicillin with an unusually broad spectrum of activity.

Authors:  L Verbist
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

7.  Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.

Authors:  W L George; R P Lewis; R D Meyer
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

8.  In vitro studies of piperacilin, a new semisynthetic penicillin.

Authors:  D J Winston; D Wang; L S Young; W J Martin; W L Hewitt
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191
  8 in total
  9 in total

1.  Early synergistic interaction between semisynthetic penicillins and aminoglycosidic aminocyclitols against Enterobacteriaceae.

Authors:  R H Glew; R A Pavuk
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

2.  Penetration of piperacillin into bronchial mucosa and sputum.

Authors:  G E Marlin; K R Burgess; J Burgoyne; G R Funnell; M D Guinness
Journal:  Thorax       Date:  1981-10       Impact factor: 9.139

3.  Comparative in vitro appraisal of piperacillin, including its activity against Salmonella typhi.

Authors:  R G Robinson; J Saunders; R Cassel; C S Block; H J Koornhof
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

4.  Comparative study of piperacillin, ticarcillin, and carbenicillin pharmacokinetics.

Authors:  B R Meyers; S Z Hirschman; L Strougo; E Srulevitch
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

5.  Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.

Authors:  L G Reimer; S Mirrett; L B Reller
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

Review 6.  Ticarcillin: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-11       Impact factor: 9.546

7.  Comparative in vitro activities of beta-lactam-tobramycin combinations against Pseudomonas aeruginosa and multidrug-resistant gram-negative enteric bacilli.

Authors:  R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

8.  Piperacillin pharmacokinetics in pediatric patients.

Authors:  C B Wilson; J R Koup; K E Opheim; L A Adelman; J Levy; T L Stull; C Clausen; A L Smith
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

9.  Biliary concentrations of piperacillin in patients undergoing cholecystectomy.

Authors:  J A Giron; B R Meyers; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.